Tulane University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Tulane University sits in the top decile of US sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count).
Tulane University: 73 sponsored US clinical trials, 22 recruiting.
Tulane University sponsors 73 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 36 completed. 6 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 6 trials.
Top-decile sponsor footprint
Tulane University ranks in the top decile of sponsors by registered trial count (#295 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
36 of 40 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
73 total, page 2 of 2
WEAICOR: Wearables to Investigate the Long Term Cardiovascular and Behavioral Impacts of COVID-19
NCT04605965
18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Life Prolonging Therapies
NCT04158245
Combination Topical Therapy for Treatment of Scalp Actinic Keratoses
NCT03996252
Counseling Hepatitis C Virus (HCV) Positive Patients for Cardiovascular Disease Risk Factors
NCT03402334
Music Therapy and Dialysis: A Pilot Investigation Into the Effectiveness of Patient-Selected Music Interventions on Physiological, Psychological, and Quality-of-Life Outcomes
NCT03925168
The Effect of Music Therapy on Newborns
NCT03987165
Text Message Program to Improve Eating Behaviors Among African Americans in New Orleans
NCT03913871
Impact of Plasma Soluble Prorenin Receptor in Obese and Type 2 Diabetic Patients
NCT03643783
Acromegaly: Patient And Physician Perspectives
NCT03613623
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS)
NCT03483662
Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis
NCT03529955
A Trial of the Ideal Protein System Versus Low Fat Diet for Weight Loss
NCT03515889
Cooking for Health Optimization With Patients
NCT03443635
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
NCT03468933
Check it: A New Approach to Controlling Chlamydia Transmission in Young People
NCT03098329
Impact of CMS Reimbursement Policy Supporting Care Coordination in Louisiana
NCT03136471
Topical Bimatoprost for Chemical Blepharoplasty
NCT02830776
Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial
NCT02552888
Vaccine Efficacy in Diabetic and Elderly Patients
NCT02675608
Longitudinal Follow-up of Brief Parenting Interventions to Reduce Risk of Child Physical Maltreatment
NCT04059185
Using D-Galactose as a Food Supplement in Congenital Disorders of Glycosylation
NCT02955264
Glutamine for the Treatment of Patients With Irritable Bowel Syndrome
NCT01414244
Clinical Trial of Dietary Protein and Blood Pressure
NCT00046566
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Tulane University pipeline
22 recruiting of 73 indexed (30% open); 36 completed (49%).
Phase mix: 6 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Hypertension (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Tulane University: open-pipeline peers nationwide
Peers matched on 73 registered trials and 30% open enrollment, not the therapeutic-area sidebar.
Tulane University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 73 trials (± recruiting share)
- Denver Health and Hospital Authority · 73 trials · 5% recruiting
- Hugo W. Moser Research Institute at Kennedy Krieger · 73 trials · 23% recruiting
- Joslin Diabetes Center · 73 trials · 10% recruiting
- Massachusetts Eye and Ear Infirmary · 73 trials · 27% recruiting
Sponsors near 30% open enrollment (± trial volume)
- New York University · 30% recruiting · 83 trials
- University of New Mexi · 30% recruiting · 76 trials
- Adverum Biotechnologies · 30% recruiting · 10 trials
- Centre hospitalier de l'Université de Montréal (CHUM) · 30% recruiting · 10 trials
Related
What to do with this Tulane University page
73 registered trials is a research-attention snapshot, not an endorsement of Tulane University or any single study.
- 22 of Tulane University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypertension is the condition Tulane University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypertension trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Tulane University pipeline card: 73 registered trials from official public datasets.Report a data error.